Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axilla | 4 | 2017 | 99 | 0.870 |
Why?
|
| Breast Neoplasms | 9 | 2021 | 2903 | 0.640 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2017 | 68 | 0.630 |
Why?
|
| Breast Diseases | 2 | 2017 | 97 | 0.610 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 86 | 0.570 |
Why?
|
| Breast | 2 | 2021 | 288 | 0.570 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 138 | 0.560 |
Why?
|
| Lymph Nodes | 2 | 2017 | 533 | 0.530 |
Why?
|
| Ultrasonography | 1 | 2017 | 695 | 0.510 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 486 | 0.310 |
Why?
|
| Ultrasonography, Mammary | 3 | 2013 | 82 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2018 | 3362 | 0.260 |
Why?
|
| Mammography | 3 | 2021 | 463 | 0.210 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 93 | 0.190 |
Why?
|
| Mass Screening | 3 | 2019 | 619 | 0.170 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 200 | 0.150 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 180 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2017 | 751 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 318 | 0.130 |
Why?
|
| Female | 13 | 2021 | 44550 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 395 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1566 | 0.110 |
Why?
|
| Middle Aged | 10 | 2019 | 25040 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 6513 | 0.100 |
Why?
|
| Hemangioma | 1 | 2010 | 60 | 0.090 |
Why?
|
| Aged | 7 | 2017 | 18423 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2017 | 8496 | 0.090 |
Why?
|
| Adult | 8 | 2018 | 25659 | 0.090 |
Why?
|
| Enteritis | 1 | 2009 | 21 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2013 | 1992 | 0.080 |
Why?
|
| Humans | 13 | 2021 | 86678 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 235 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 121 | 0.080 |
Why?
|
| Gadolinium DTPA | 3 | 2014 | 261 | 0.080 |
Why?
|
| Contrast Media | 4 | 2014 | 1078 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 294 | 0.070 |
Why?
|
| Reflex, Startle | 1 | 2006 | 32 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 4214 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 212 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 1939 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 738 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2006 | 711 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2009 | 730 | 0.050 |
Why?
|
| Biopsy | 2 | 2018 | 1163 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2601 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 944 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1188 | 0.030 |
Why?
|
| Meglumine | 1 | 2014 | 39 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2706 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 132 | 0.030 |
Why?
|
| Fats | 1 | 2011 | 12 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 5214 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2271 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 813 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 95 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 18 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1673 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 38 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2008 | 81 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2011 | 563 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2008 | 113 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 3968 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 217 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2008 | 241 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 130 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 663 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5420 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 1313 | 0.010 |
Why?
|
| Male | 3 | 2010 | 40988 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 726 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3680 | 0.010 |
Why?
|